In the elderly, immunosenescence and malnourishment can contribute to increased risk and severity of upper respiratory tract infections (URTI). Gold kiwifruit (Actinidia chinensis 'Hort16A') contains nutrients important for immune function and mitigation of symptoms of infection, including vitamins C and E, folate, polyphenols and carotenoids. The objective of the present study was to evaluate whether regular consumption of gold kiwifruit reduces symptoms of URTI in older people, and determine the effect it has on plasma antioxidants, and markers of oxidative stress, inflammation and immune function. A total of thirty-two community-dwelling people ($ 65 years) participated in a randomised crossover study, consuming the equivalent of four kiwifruit or two bananas daily for 4 weeks, with treatments separated by a 4-week washout period. Participants completed the Wisconsin Upper Respiratory Symptom Survey-21 daily, and blood samples were collected at baseline and at the end of each treatment and washout period. Gold kiwifruit did not significantly reduce the overall incidence of URTI compared with banana, but significantly reduced the severity and duration of head congestion, and the duration of sore throat. Gold kiwifruit significantly increased plasma vitamin C, a-tocopherol and lutein/zeaxanthin concentrations, and erythrocyte folate concentrations, and significantly reduced plasma lipid peroxidation. No changes to innate immune function (natural killer cell activity, phagocytosis) or inflammation markers (high-sensitivity C-reactive protein, homocysteine) were detected. Consumption of gold kiwifruit enhanced the concentrations of several dietary plasma analytes, which may contribute to reduced duration and severity of selected URTI symptoms, offering a novel tool for reducing the burden of URTI in older individuals.
Objective: To assess whether there are any differences in the postprandial physiological responses to apple drink (control), calcium phosphate (tricalcium phosphate, TCP) and high-calcium skim milk (HCSM) with or without additional magnesium in postmenopausal women. Design: Randomized, controlled, cross-over. Measurements after overnight fast before each drink, and subsequently every hour for 8 h postprandially. Results: There was no difference in baseline serum calcium, PTH or C-telopeptide levels between drinks. There were no overall differences in serum calcium after apple or after either milk, but after TCP serum calcium increased from a baseline value of 2.12 AE 0.08 to a mean peak of 2.21 AE 0.12 mmol=l (s.d.) (P ¼ 0.0001) after 2 h. There were no significant differences in serum PTH after either apple or HCSM þ Mg. In contrast, after TCP, serum PTH decreased from 2.76 AE 0.69 to a mean nadir of 2.23 AE 0.65 pmol=l (P ¼ 0.0001) after 1 h, and after HCSM, it decreased from 2.71 AE 0.78 to a mean nadir of 2.51 AE 0.87 pmol=l (P ¼ 0.007) after 2 h. Serum C-telopeptides decreased after each drink, reaching nadirs after 5 h. At this time the serum values for each of the high calcium drinks were not different from each other, but were significantly less than for apple (P ¼ 0.001 for each), being 0.22 AE 0.09 ng=ml for apple, 0.15 AE 0.08 for TCP, 0.14 AE 0.07 for HCSM and 0.16 AE 0.07 for HCSM þ Mg. Conclusion: Despite differences in serum calcium and PTH responses to the three high-calcium drinks that we tested, there was no distinguishable difference in serum C-telopeptides between high calcium drinks.
The aim of this study was to investigate the impact of magnesium-enriched, high-calcium milk on serum parathyroid hormone (PTH) and biochemical markers of bone turnover in postmenopausal women. We recruited 50 healthy postmenopausal women to take part in this randomised controlled study. Half of the women consumed two serves of high-calcium skim milk enriched with magnesium (milk group) and half consumed two serves apple drink per day (apple group), each for 4 weeks. The milk provided 1200 mg calcium and an additional 106 mg magnesium. We investigated the responses of serum PTH, as well as the serum and urinary calcium, magnesium and biochemical markers of bone turnover. There was no effect of time or drink on the clinical biochemistry, serum PTH or urine markers of bone resorption (free deoxypyridinoline and N-telopeptides). Serum C-telopeptides (CTX), another marker of bone resorption, did not change with time in the apple group. However, in the milk group, serum CTX deceased significantly from 0.43 +/- 0.04 ng/mL to 0.32 +/- 0.02 at 2 weeks (p < 0.0001) and 0.28 +/- 0.02 at 4 weeks (p < 0.0001). In the milk group, urinary calcium and magnesium each increased during the night but not during the day. Overall, these data suggest that milk has an antiresorptive effect on bone, but that this is not accompanied by measurable changes in serum PTH.
BACKGROUND: Goat milk is recognised as nutritious, with benefits to growth and skeletal development. The initial aim of this study was to investigate the effect of three different goat milk formulae -a whole milk, a skim milk and a goat milk growing-up formula fortified with pre-and probiotics (Formula 1) -on mineral absorption and retention in rats. The effect of long-term intake of the fortified formula diet on peak bone mass and post-ovariectomy bone loss in rats was then investigated in a follow-up study and was assessed by bone density dual-energy X-ray absorptiometry and biomechanical testing of bone ex vivo.
The purpose of this study was to assess the agreement between the 24 h diet recall and a short 17-item 24 h food intake recall in assessing calcium intake. The calcium intakes of 21 women over the age of 50 were assessed by both methods on four occasions. The mean calcium intakes were similar using both methods, being 1034+/-398 mg/day by 24 h diet recall and 822+/-412 mg/day (SD) by 17-item 24 h food intake recall. The 17-item 24 h food intake recall tended to underestimate calcium intake compared with the 24 h diet recall, with the limits of agreement being between -1197 and -727 below and 370 and 682 mg/day above 24 h diet recall values over the four assessments. The 17-item 24 h food intake recall identified 8% more women with inadequate calcium intakes than the 24 h diet recall method did. Although there is poor agreement in calcium intake between the 24 h diet recall method and the 17-item 24 h food intake recall, the latter provides a quick and simple means for assessing extremes of calcium intake and whether day to day calcium intake is adequate.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.